共 78 条
[1]
Tang A(2018)Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review Radiology 286 29-48
[2]
Bashir MR(2018)LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma Abdominal radiology 43 149-157
[3]
Corwin MT(2019)Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma Journal of magnetic resonance imaging : JMRI 49 e205-e215
[4]
Fowler KJ(2019)Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review Gastroenterology 156 976-986
[5]
Potretzke TA(2010)Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors World journal of gastrointestinal oncology 2 407-416
[6]
Hope TA(2011)Management of hepatocellular carcinoma: an update Hepatology (Baltimore, Md) 53 1020-1022
[7]
Costa EA(2021)A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents International journal of medical sciences 18 3066-3081
[8]
Wilson SR(2007)Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging Investigative radiology 42 105-115
[9]
Kierans AS(2015)Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase Abdominal imaging 40 2313-2322
[10]
Makkar J(2018)Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. 28 2549-2560